On October 30, Teradyne fell 5.14% in Pre-Market Trading, trading at $281.615 per share with turnover of $2.3993 million.
The move coincided with continued market digestion of post-earnings fourth-quarter guidance pressure and the pace of AI test order conversion, while Baird cut its price target on Teradyne to $385 from $420, weighing on near-term sentiment.
Teradyne had reported third-quarter adjusted EPS of $2.29 and revenue of $1.306 billion, both above market expectations of $2.04 to $2.09 and $1.264 billion, respectively. Even so, recent trading has shown investors shifting focus from the earnings beat to forward guidance and demand visibility. ARK had previously added to its position, but that support was insufficient to offset the impact of the target reduction and cautious positioning.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments